---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-019553"
form_type: "8-K"
ticker: "RBOT"
cik: "0001812173"
company_name: "Vicarious Surgical Inc."
filed_at: "2024-03-04T23:59:59+00:00"
generated_at: "2026-06-05T04:51:03.874095+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Vicarious Surgical Q4 2023 GAAP net loss $13.1M; 2024 cash burn guided ~$50M

## Summary
- Q4 2023 GAAP net loss $13.1M ($0.06/sh); adjusted net loss $14.6M ($0.07/sh), improving from $19.9M ($0.16/sh) in Q4 2022.
- Full year 2023 GAAP net loss $71.1M ($0.49/sh); adj net loss $76.3M ($0.52/sh); cash burn $63.4M met objective.
- Cash and investments $98.2M at year-end; 2024 cash burn guidance narrowed to ~$50M.
- Signed fourth major hospital partnership with Intermountain Health; total partner hospitals exceed 250.
- V1.0 system on track for spring cadaveric testing; integration expected fall 2024; appointed Randy Clark President.

## SEC filing metadata
- accession: 0001213900-24-019553
- form_type: 8-K
- ticker: RBOT
- cik: 0001812173
- company_name: Vicarious Surgical Inc.
- filed_at: 2024-03-04T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812173/000121390024019553/0001213900-24-019553-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812173/000121390024019553/ea0201080-8k_vicarious.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-019553
- JSON: https://secwatch.observer/filing/0001213900-24-019553.json
- Plain text: https://secwatch.observer/filing/0001213900-24-019553.txt

## Key facts
- Earnings Releases
  Vicarious Surgical Inc. reported fourth quarter and full year ended December 31, 2023 results: net income GAAP net loss for the fourth quarter was $13.1 million, equating to a net loss per share of $0.06, as compared to a GAAP, EPS GAAP net loss for the fourth quarter was $13.1 million, equating to a net loss per share of $0.06, as compared to a GAAP. Guidance reaffirmed.
  - Period: fourth quarter and full year ended December 31, 2023
  - Net income: GAAP net loss for the fourth quarter was $13.1 million, equating to a net loss per share of $0.06, as compared to a GAAP
  - EPS: GAAP net loss for the fourth quarter was $13.1 million, equating to a net loss per share of $0.06, as compared to a GAAP
  - Guidance: reaffirmed
  - Result: reported results
  source text: On March 4, 2024, Vicarious Surgical Inc. (the “Company”) issued a press release announcing its results for the fourth quarter and full year ended December 31, 2023 and providing a business update.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1812173/000121390024019553/0001213900-24-019553-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.